Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.8 USD | +0.69% | -5.07% | +2.65% |
May. 09 | Stifel Adjusts Price Target on C4 Therapeutics to $14 From $13, Maintains Buy Rating | MT |
May. 08 | C4 Therapeutics Shares Decline as Q1 Revenue Misses Estimates | MT |
- Stock Market
- Equities
- CCCC Stock
- News C4 Therapeutics, Inc.